Opendata, web and dolomites

ExoSensor

A Nano-photoelectric Exosome Biosensor for Point-of-care Diagnosis of Early-stage Cancer

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 ExoSensor project word cloud

Explore the words cloud of the ExoSensor project. It provides you a very rough idea of what is the project "ExoSensor" about.

university    positive    quantitatively    monitoring    platform    single    confirm    animal    detection    prototype    transfer    fellowship    guy    integrating    biosensor    ideal    signalling    diagnosis    contributions    appealing    novelty    college    markers    molecular    researcher    clinical    analytical    collaborators    advise    negative    commercial    biomarkers    interdisplinary    training    circulating    chemistry    accurate    final    resides    academic    fabricate    thomas    therapeutics    industrial    astrazeneca    marker    biology    portable    techniques    imaging    poct    pinpointing    handling    exosome    kings    samples    cooperation    easily    engineering    false    utmost    seek    tests    3d    pancreatic    round    london    valuable    cardiff    nanotechnology    disease    quality    hospital    universal    creatively    biomarker    exosomes    dual    printing    tumour    avoiding    cell    king    secondment    protein    toxicology    reliability    gpc1    ltd    optical    nanosensing    diagnostics    reservoir    exosensor    health    st    accessible    cancer    simultaneous    microscopy    sensitive    mentoring    validation    rapid    stage    unmet    synergetic    printed    electrochemical    feasibility   

Project "ExoSensor" data sheet

The following table provides information about the project.

Coordinator
KING'S COLLEGE LONDON 

Organization address
address: STRAND
city: LONDON
postcode: WC2R 2LS
website: www.kcl.ac.uk

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country United Kingdom [UK]
 Project website https://kclpure.kcl.ac.uk/portal/en/projects/exosensor--a-nanophotoelectric-exosome-biosensor-for-pointofcare-diagnosis-of-earlystage-cancer
 Total cost 183˙454 €
 EC max contribution 183˙454 € (100%)
 Programme 1. H2020-EU.1.3.2. (Nurturing excellence by means of cross-border and cross-sector mobility)
 Code Call H2020-MSCA-IF-2016
 Funding Scheme MSCA-IF-EF-ST
 Starting year 2017
 Duration (year-month-day) from 2017-10-11   to  2019-10-10

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    KING'S COLLEGE LONDON UK (LONDON) coordinator 183˙454.00

Map

 Project objective

Tumour-derived circulating exosomes are an ideal, easily accessible reservoir of cancer biomarkers to assess disease processes. Quantitatively pinpointing exosome tumour markers, a clinical field of an unmet need is appealing, yet challenging. The main objectives of the proposal are to develop an integrated dual-signalling exosome biosensor (ExoSensor) for rapid and specific detection of GPC1 exosomes and fabricate a 3D-printed portable prototype for POCT diagnosis of pancreatic cancer, offering an universal technology for clinical cancer diagnosis through quantitatively monitoring the protein marker of cancer-derived exosomes, in a simple way. The novelty resides in creatively achieving accurate, sensitive, and simultaneous detection of exosomes by integrating two synergetic methods (optical and electrochemical) on one single nanosensing platform, avoiding false positive/negative results to the utmost and ensuring the reliability of tests. This European Fellowship at Kings College London will provide the researcher with advanced technical training in molecular biology, exosome, cancer cell and animal handling, analytical chemistry and microscopy and imaging techniques, as well as academic mentoring in research management. A secondment to Cardiff University will seek and confirm the best possible biomarker(s). Another secondment to the industrial partner AstraZeneca Ltd will offer access to various exosomes research (diagnostics, toxicology and therapeutics) and evaluate the feasibility of commercial transfer if possible. Guy’s, St Thomas, and King’s College Hospital (part of King’s Health Partners) will provide valuable clinical samples for final validation stage. Other collaborators will advise on 3D-printing, pancreatic cancer and biomarkers. These interdisplinary contributions are essential and well-related to the proposal research, fostering high-quality cooperation from biology, chemistry, engineering, nanotechnology and clinical areas the other way round.

 Publications

year authors and title journal last update
List of publications.
2019 Farid N. Faruqu, Julie Tzu-Wen Wang, Lizhou Xu, Luke McNickle, Eden Ming-Yiu Chong, Adam Walters, Mark Gurney, Aled Clayton, Lesley A. Smyth, Robert Hider, Jane Sosabowski, Khuloud T. Al-Jamal
Membrane Radiolabelling of Exosomes for Comparative Biodistribution Analysis in Immunocompetent and Immunodeficient Mice - A Novel and Universal Approach
published pages: 1666-1682, ISSN: 1838-7640, DOI: 10.7150/thno.27891
Theranostics 9/6 2020-02-27
2018 Farid N. Faruqu, Lizhou Xu, Khuloud T. Al-Jamal
Preparation of Exosomes for siRNA Delivery to Cancer Cells
published pages: , ISSN: 1940-087X, DOI: 10.3791/58814
Journal of Visualized Experiments 142 2020-02-27

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "EXOSENSOR" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "EXOSENSOR" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.3.2.)

CYBERSECURITY (2018)

Cyber Security Behaviours

Read More  

ROSETTA (2020)

Deciphering the Role of aberrant glycOSylation in the rEsponse to Targeted TherApies for breast cancer

Read More  

LiverMacRegenCircuit (2020)

Elucidating the role of macrophages in liver regeneration and tissue unit formation

Read More